Cargando…

Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey

RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) has a far-reaching impact on both patients and care partners, which can be further compounded by frequent complications such as anemia. This study assessed the burden experienced by patients with CKD and the care partners of patients with CKD,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalopoulos, Steven N., Gauthier-Loiselle, Marjolaine, Aigbogun, Myrlene Sanon, Serra, Elizabeth, Bungay, Rebecca, Clynes, Diana, Cloutier, Martin, Kahle, Erin, Guérin, Annie, Farag, Youssef M.K., Wish, Jay B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988003/ https://www.ncbi.nlm.nih.gov/pubmed/35402892 http://dx.doi.org/10.1016/j.xkme.2022.100439

Ejemplares similares

The societal economic burden of autosomal dominant polycystic kidney disease in the United States
por: Cloutier, Martin, et al.
Publicado: (2020)

Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective
por: Gauthier-Loiselle, Marjolaine, et al.
Publicado: (2021)

Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019)

Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2020)

Effect of Anemia on Physical Function and Physical Activity in CKD: The National Health and Nutrition Examination Survey, 1999–2016
por: Farag, Youssef M.K., et al.
Publicado: (2023)

Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study
por: Schein, Jeff, et al.
Publicado: (2022)

Risk factors associated with newly diagnosed attention-deficit/hyperactivity disorder in adults: a retrospective case-control study
por: Schein, Jeff, et al.
Publicado: (2023)

Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors for the Treatment of Anemia in CKD: Additional Pieces of the Jigsaw Puzzle
por: Wish, Jay B.
Publicado: (2021)

Iron Deficiency in CKD Without Concomitant Anemia
por: Wish, Jay B., et al.
Publicado: (2021)

Severity of memory impairment in the elderly: Association with health care resource use and functional limitations in the United States
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2017)

Assessment of costs associated with adverse events in patients with cancer
por: Wong, William, et al.
Publicado: (2018)

Impact of agitation in long‐term care residents with dementia in the United States
por: Fillit, Howard, et al.
Publicado: (2021)

Radiographic Imaging in Autosomal Dominant Polycystic Kidney Disease: A Claims Analysis
por: Sanon Aigbogun, Myrlene, et al.
Publicado: (2021)

Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2019)

Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia
por: Halpern, Rachel, et al.
Publicado: (2018)

Variation in health plan coverage of ESAs for anemia due to chronic kidney disease
por: Margaretos, NikoLetta M, et al.
Publicado: (2021)

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System
por: Jones, Eddie, et al.
Publicado: (2021)

Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States
por: Hernandez-Pastor, Luis, et al.
Publicado: (2023)

Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
por: Wish, Jay B.
Publicado: (2021)

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk
por: Ganz, Tomas, et al.
Publicado: (2020)

Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
por: Sanon Aigbogun, Myrlene, et al.
Publicado: (2021)

A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients
por: Bent-Ennakhil, Nawal, et al.
Publicado: (2017)

The Influence of Inflammation on Anemia in CKD Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2020)

Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review
por: Pergola, Pablo E., et al.
Publicado: (2019)

Chapter 1: Diagnosis and evaluation of anemia in CKD
Publicado: (2012)

Diagnosis Patterns of CKD and Anemia in the Japanese Population
por: Kimura, Tomomi, et al.
Publicado: (2020)

The Symptoms Targeted for Monitoring in a Web-Based Tracking Tool by Caregivers of People With Dementia and Agitation: Cross-Sectional Study
por: Rockwood, Kenneth, et al.
Publicado: (2019)

Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis
por: Gauthier-Loiselle, Marjolaine, et al.
Publicado: (2021)

Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)
por: Tsang, Yuen, et al.
Publicado: (2023)

Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis
por: Sargent, Therese, et al.
Publicado: (2023)

Chapter 2: Use of iron to treat anemia in CKD
Publicado: (2012)

Interleukin-6 Contributes to the Development of Anemia in Juvenile CKD
por: Akchurin, Oleh, et al.
Publicado: (2018)

Roxadustat for CKD-related Anemia in Non-dialysis Patients
por: Coyne, Daniel W., et al.
Publicado: (2020)

Chapter 4: Red cell transfusion to treat anemia in CKD
Publicado: (2012)

Anemia and Iron Deficiency in Children with Chronic Kidney Disease (CKD): Data from the Know-Ped CKD Study
por: Lee, Keum Hwa, et al.
Publicado: (2019)

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer
por: Gallagher, Christopher M., et al.
Publicado: (2016)

Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
por: Gallagher, Christopher M., et al.
Publicado: (2016)

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
por: Aigbogun, Myrlene S, et al.
Publicado: (2018)

Chapter 3: Use of ESAs and other agents to treat anemia in CKD
Publicado: (2012)

Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease
por: Gutiérrez, Orlando M.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_21aad4lnral4fgt09sf25rvbso